Sagitta Biotech
PrivateLast Round
VC Round
Apr 23, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sagitta Biotech is a biotechnology company that develops active non-replicating virosome platforms for vaccines, targeted oncology immunotherapies, and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sagitta Biotech Comparables
Compare Sagitta Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oncovita | 83% | |
| Seagull BioSolutions | 80% | |
| Ziphius Vaccines | 77% | |
Sagitta Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 23, 2026 | ||||
| Seed | Jul 30, 2025 | ||||
| Accelerator | Dec 16, 2024 |
Sagitta Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors grew 69% MoM.
- Dec 9, 2025
Monthly visitors increased 126% MoM, reaching 3.1K.
Sagitta Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sagitta Biotech's valuation, stock price, and market status.